Market Research Logo

Global Migraine Market: Industry Analysis & Outlook (2019-2023)

Global Migraine Market: Industry Analysis & Outlook (2019-2023)

Migraine is a neurological disorder involving nerve pathways and brain chemicals. It is characterized by a severe throbbing recurring pain on one side of the head. Nausea, visual imparity and sensitivity to light & sound are common symptoms of migraine. There are different types of migraines that are usually identified by its predominant symptoms. Generally, migraine can be chronic or episodic, depending upon the duration of headaches. Migraine usually acompasses through four stages: Prodrome, Aura, Headaches and Post-drome. Drugs for migraine headaches can relieve the pain and symptoms of a migraine attack and help prevent further migraine attacks. Migraine can be treated with two types of drugs: abortive and preventive that depends upon the intensity of a migraine attack.

The global migraine market has grown considerably over last few years. Different preventative drugs were launched by various biotech and pharmaceuticals firms and a lot more are under a development process. Factors such as increasing female population, rising health expenditure, accelerating economic growth, increasing cigarette consumption, rising prevalence of migraine and unmet medical needs have driven the global migraine market. The new CGRP drugs are expected to push the global migraine market growth in future.

The U.S. held the major share in the global migraine market. The rising migraine population in the U.S. is inducing high demand for proper medication, which in turn drives the U.S. migraine market towards higher verticals. The adoption of migraine treatment though the CGRP drugs is expected to grow the U.S. migraine market further.

The global migraine market is dominated by four key players such as Eli Lily and Co., Amgen Inc., Teva Pharmaceuticals and Alder Biopharmaceuticals. Their upcoming launches of migraine preventative drugs are expected to change the scenario of the overall migraine treatments. Furthermore, these leading players are consistently directing their strategic efforts to boost up the growth of the global migraine market.


1. Market Overview
1.1 Migraine
Table 1: Migraine
1.2 Types of Migraine
Table 2: Difference between Episodic and Chronic Migraine
1.3 Stages of Migraine
Table 3: Stages of Migraine
1.4 Diagnosis Procedures
Table 4: Diagnosis Procedures
1.5 Migraine Treatment
1.6 CGRP – A New Era of Migraine Treatment
2. Global Market Analysis
2.1 Global Migraine Market by Value
Table 5: Global Migraine Market by Value (2014-2018)
2.2 Global Migraine Market Forecast by Value
Table 6: Global Migraine Market Forecast by Value (2019-2023)
2.3 Global Migraine Market by Drug Type
Table 7: Global Migraine Market by Drug Type (2018)
2.4 Global Therapeutic Botulinum Toxin Market Forecast by Value
Table 8: Global Therapeutic Botulinum Toxin Market Forecast by Value (2018-2023)
2.5 Global CGRP Drug Market
2.5.1 Global Erenumab Drug Revenue Forecast
Table 9: Global Erenumab Drug Revenue Forecast (2019-2023)
2.5.2 Global Galcanezumab Drug Revenue Forecast
Table 10: Global Galcanezumab Drug Revenue Forecast (2019-2023)
2.5.3 Global Fremanezumab Drug Revenue Forecast
Table 11: Global Fremanezumab Drug Revenue Forecast (2019-2023)
2.5.4 Global Eptinezumab Drug Revenue Forecast
Table 12: Global Eptinezumab Drug Revenue Forecast (2020-2023)
3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Total Migraine Population Forecast
Table 13: The U.S. Total Migraine Population Forecast (2018-2023)
3.1.2 The U.S. Total Diagnosed Migraine Population Forecast
Table 14: The U.S. Total Diagnosed Migraine Population Forecast (2018-2023)
3.1.3 The U.S. Diagnosed & Treated Adult Migraine Population Forecast
Table 15: The U.S. Diagnosed and Treated Adult Migraine Population Forecast
(2018-2023)
3.1.4 The U.S. Migraine Treatment by Specialty
Table 16: The U.S. Migraine Treatment by Specialty (2018)
3.1.5 The U.S. Migraine Treated Population by Drug Type
Table 17: The U.S. Migraine Treated Population by Drug Type (2018)
3.1.6 The U.S. Diagnosed Adult Migraine Population with Triptan Treatment Forecast
Table 18: The U.S. Diagnosed Adult Migraine Population with Triptan Treatment Forecast (2018-2023)
3.1.7 The U.S. Migraine Prophylaxis Market by Treatment
Table 19: The U.S. Migraine Prophylaxis Market by Treatment (2018)
3.1.8 The U.S. Diagnosed Adult Migraine Population with Acute Treatment Forecast
Table 20: The U.S. Diagnosed Adult Migraine Population with Acute Treatment Forecast (2018-2023)
3.1.9 The U.S. Erenumab Drug Revenue and Treated Patients Forecast
Table 21: The U.S. Erenumab Drug Revenue and Treated Patients Forecast (2019-2023)
3.1.10 The U.S. Galcanezumab Drug Revenue and Treated Patients Forecast
Table 22: The U.S. Galcanezumab Drug Revenue and Treated Patients Forecast (2019-2023)
3.1.11 The U.S. Fremanezumab Drug Revenue and Treated Patients Forecast
Table 23: The U.S. Fremanezumab Drug Revenue and Treated Patients Forecast (2019-2023)
3.2 Europe
3.2.1 Europe Total Migraine and Diagnosed Population Forecast
Table 24: Europe Total Migraine and Diagnosed Population Forecast (2018-2023)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Female Population
Table 25: Global Female Population (2014-2018)
4.1.2 Increasing Cigarette Consumption
Table 26: Global Cigarette Consumption (2014-2018)
4.1.3 Accelerating Economic Growth
Table 27: Global GDP Per Capita (2014-2018)
4.1.4 Increasing Healthcare Spending
Table 28: Global Healthcare Spending Per Capita (2014-2018)
4.1.5 Increasing Stress Levels
4.1.6 Unmet Medical Needs
4.1.7 Prevalence of Migraine at High Rate
4.2 key Trends and Developments
4.2.1 Progressing CGRP: Targeting Drug Pipeline
Table 29: Progressing CGRP - Targeting Drug Pipeline
4.2.2 Branded Acute Treatment for Episodic Migraine
Table 30: Branded Acute Treatment for Episodic Migraine
4.2.3 Growing Awareness for Migraine and its Treatments
4.2.4 Development of Additional Migraine Therapeutics
4.3 Challenges
4.3.1 Adverse Effects of Drugs
4.3.2 Lack of Proper Diagnosis
4.3.3 Increased Preference for Alternative Therapies
4.3.4 Regulatory Challenges
4.3.5 High Cost Associated
5. Competitive Landscape
5.1 Global Market
5.1.1 Key Players – Market Cap Comparison
Table 31: Key Players – Market Cap Comparison
5.1.2 Key Players – Revenue Comparison
Table 32: Key Players – Revenue Comparison (2018)
5.1.3 Key Players – R&D Comparison
Table 33: Key Players – R&D Comparison (2018)
5.2 The U.S. Market
5.2.1 Key Players - The U.S. CGRP Drugs for Episodic Migraine Market Penetration Forecast
Table 34: key Players - The U.S. CGRP Drugs for Episodic Migraine Market Penetration Forecast (2018-2023)
5.2.2 Key Players - The U.S. CGRP Drugs for Chronic Migraine Market Share Forecast
Table 35: Key Players - The U.S. CGRP Drugs for Chronic Migraine Market Share Forecast (2018-2023)
6. Company Profiles
6.1 Eli Lilly and Company
6.1.1 Business Overview
Table 36: Eli Lilly and Company Revenue by Segments (2018)
6.1.2 Financial Overview
Table 37: Eli Lilly and Company Revenue and Net Income (2014-2018)
6.1.3 Business Strategies
Table 38: Eli Lilly and Company Research and Development Expenditure (2016-2018)
6.2 Amgen Inc.
6.2.1 Business Overview
Table 39: Amgen Inc. Revenue by Geographic Region (2018)
6.2.2 Financial Overview
Table 40: Amgen Inc. Total Revenue and Net Income (2014-2018)
6.2.3 Business Strategies
Table 41: Amgen Inc. Research and Development Expenditure (2016-2018)
6.3 Teva Pharmaceuticals
6.3.1 Business Overview
Table 42: Teva Pharmaceuticals Revenue by Segments (2018)
6.3.2 Financial Overview
Table 43: Teva Pharmaceuticals Revenue and Net Income (2014-2018)
6.3.3 Business Strategies
Table 44: Teva Pharmaceuticals R&D Expenditure (2016-2018)
6.4 Alder Biopharmaceuticals
6.4.1 Business Overview
Table 45: Alder Pharmaceuticals Pipeline Overview (2018)
6.4.2 Financial Overview
Table 46: Alder Biopharmaceuticals Revenue and Net Income (2014-2018)
6.4.3 Business Strategies
Table 47: Alder Biopharmaceuticals Research & Development Expenditure
(2016-2018)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report